HoldStation's TVL has become the fourth in the ZKSync ecosystem, with a monthly increase of 43%

Gold's frustrating paradox: Falling yields and a weaker dollar can't stop the selloff

Update Version 3 - The US Food and Drug Administration (FDA) has approved Inovio’s drug to treat a rare throat disease; the company's stock price soared.

Omeros Grants CEO Demopulos Performance-Based Options for Up to 500,000 Shares

Updated version 1 - The U.S. Food and Drug Administration (FDA) has approved Inovio's drug for treating a rare throat disease; the company's stock price surged.